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We describe a patient with a background of unex-
plained recurrent miscarriages who was diag-
nosed with Wilson’s disease and subsequently
gave birth to two children after treatment was
commenced.
Introduction
Recurrent miscarriage is a less recognized feature
of Wilson’s disease and adequate treatment can
alter the outcome of pregnancies favourably.
Wilson’s disease is a recessively inherited disorder
of copper metabolism due to mutations in the
ATP7B gene, which encodes for a copper-
transporting P-type ATPase. Recurrent miscar-
riage is a complication of untreated Wilson’s
disease. It has been reported that miscarriages
can predate neurological symptoms,
1 and treat-
ment with copper chelation improves the rate of
successful pregnancies.
1,2
Case report
In May 2007, a 41-year-old woman of Pakistani
origin presented with a three-year history of
tremor. She had two other siblings affected with
Wilson’s disease, and their parents were consan-
guineous. She presented late because she moved
between cities frequently. On examination, she
had very obvious Kayser-Fleischer rings in both
eyes (Figure 1). She had action tremor of both
upper limbs and an unsteady ataxic gait.
Investigations conﬁrmed the strong clinical
suspicion of Wilson’s disease. Serum copper was
0.6 mg/L (0.7–1.6 mg/L). Serum caeruloplasmin
was 0.13 g/L (0.2–0.5 g/L). Urinary copper
excretion was 124 μg/24 hr (<50 μg/24 hr). All
other serological tests including liver enzymes
were normal. Magnetic resonance imaging of the
brain showed diffuse abnormal high signal in
both thalami, cerebral peduncles, midbrain and
pons consistent with Wilson’s disease. Gene
sequencing of ATP7B gene showed that she was
heterozygous for c.3008 C >T; p.Ala1003Val
novel amino acid change.
However, her other main clinical problem was
recurrent miscarriages. Up to the age of 34 years,
corresponding to four years prior to onset of
neurological symptoms, she had 10 miscarriages,
all in the ﬁrst trimester. Her menarche occurred
aged 15, and her ﬁrst pregnancy and miscarriage
aged 18. Previous investigations including tests
for antiphospholipid syndrome and exploratory
laparoscopy and hysteroscopy revealed no
causes for her miscarriages.
Penicillamine was commenced in June 2007.
She responded neurologically but compliance
was poor due to side-effects and anxieties of tera-
togenicity. She was found pregnant six months
into suboptimal therapy, her ﬁrst on treatment, at
16 weeks gestation when she stopped treatment
herself. She had cervical incompetence diagnosed
at 19 weeks, likely to be caused by repeated endo-
scopic removal of products of reception for her
previous miscarriages. She gave birth to a male
infant of 574 g at 24 weeks gestation by emergency
Caesarean section due to spontaneous rupture of
membrane and cord prolapse. He died unexpect-
edly aged eight weeks due to aspiration pneumo-
nia. An autopsy was declined, and placental
copper was 0.33 μg/g (0.2–0.5 μg/g). She became
pregnant for the 12th time in March 2009, and
was admitted to hospital under the obstetrician
for strict bed rest to avoid complications from cer-
vical incompetence. She remained fully compliant
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1with medication (penicillamine 1 g/day, zinc
acetate 150 mg/day, pyridoxine 50 mg/week)
throughout this pregnancy and neurologically
there were minimal cerebellar signs. She delivered
a healthy female infant of 2430 g in July 2009 at
34 weeks by elective Caesarean section. She is
developing normally and placental copper was
0.15 μg/g. She soon became pregnant for the 13th
time, and the outcome was awaited.
Discussion
Recurrent miscarriage is deﬁned as the occurrence
of three or more pregnancy losses before 20 weeks
of gestation and most cases are idiopathic or mul-
tifactorial.
3 It affects 1% of all conceiving couples
and 15% of clinically recognized pregnancies are
lost before 20 weeks. It is common in untreated
Wilson’s disease according to a study in India
(30%), which followed a cohort of 16 female
Wilson’s disease patients.
4 However, more than
half of the pregnancies in untreated patients
went full term with no complications, suggesting
pregnancy outcome was multifactorial. Recent
laboratory work showed that the gene product of
ATP7B has the role of transporting copper from
the placenta to the maternal circulation,
5 implying
that its normal functioning prevents copper over-
load in the fetus. Thus we hypothesize that with
ATP7B dysfunction, excess copper remains in the
fetus due to defective clearance mechanism in
the ﬁrst trimester, causing free radical formation,
oxidative damage and eventually fetal loss. This
is supported by report of copper accumulation in
placenta and fetus in untreated Wilson’s disease.
6
This case highlights the importance of consid-
ering Wilson’s disease as a cause of recurrent mis-
carriage. It is an important differential diagnosis
to antiphospholipid syndrome as far as pregnancy
issues are concerned, especially in neurology prac-
tice as both conditions are readily treatable.
Although multiple factors were implicated in our
case, full treatment for Wilson’s disease made a
critical difference in pregnancy outcome, together
with dedicated obstetric care. However, there is
currently no consensus on treatment regimen for
Wilson’s disease during pregnancy and more
focused studies in this area would improve treat-
ment selection. It is worth enquiring fora personal
and family history of early miscarriage in sus-
pected Wilson’s disease as this may prompt
earlier diagnosis. Further, for female patients of
child-bearing age, they should be counselled to
receive effective treatment before planning preg-
nancy. Early involvement of obstetric care is also
recommended to avoid similar problems to our
patient’s unfortunate neonatal loss.
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Figure 1
Kayser-Fleischer ring in the right eye of our
patient
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